Catalyst Wire Dossier Catalyst Wire Dossier

human recombinant alkaline phosphatase (recAP)

human recombinant alkaline phosphatase · AM-Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for human recombinant alkaline phosphatase (recAP), covering 2020-03-23 to 2020-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI [Phase 2]

See pricing